Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.verified

603520.SS

Price:

$9.49

Market Cap:

$4.16B

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-03-09

Stock Exchange

SHH

Ticker

603520.SS

The ROE as of December 2025 (TTM) for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) is -1.11%

According to Zhejiang Starry Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is -1.11%. This represents a change of 299.59% compared to the average of -0.28% of the last 4 quarters.

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) Historical ROE (quarterly & annually)

How has 603520.SS ROE performed in the past?

The mean historical ROE of Zhejiang Starry Pharmaceutical Co.,Ltd. over the last ten years is 8.69%. The current -1.11% ROE has changed -112.82% with respect to the historical average. Over the past ten years (40 quarters), 603520.SS's ROE was at its highest in in the June 2020 quarter at 8.80%. The ROE was at its lowest in in the December 2022 quarter at -5.73%.

Quarterly (TTM)
Annual

Average

8.69%

Median

10.10%

Minimum

-4.07%

Maximum

17.11%

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Zhejiang Starry Pharmaceutical Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 62.70%

Maximum Annual ROE = 17.11%

Minimum Annual Increase = -174.02%

Minimum Annual ROE = -4.07%

Quarterly (TTM)
Annual
YearROEChange
2024-1.87%-174.02%
20232.52%-161.94%
2022-4.07%-127.37%
202114.89%13.70%
202013.09%-23.46%
201917.11%62.70%
201810.51%8.42%
20179.70%3.19%
20169.40%-39.96%
201515.65%-2.66%

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) Average ROE

How has 603520.SS ROE performed in the past?

The current ROE of Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-1.14%

5-year avg

4.91%

10-year avg

8.69%

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) ROE vs. Peers

How is 603520.SS’s ROE compared to its peers?

Zhejiang Starry Pharmaceutical Co.,Ltd.’s ROE is greater than Zhuhai Rundu Pharmaceutical Co., Ltd. (-4.71%), greater than Wuhan Hiteck Biological Pharma Co.,Ltd (-8.03%), less than Yabao Pharmaceutical Group Co., Ltd (7.80%), less than Jinhe Biotechnology Co. Ltd. (5.45%), less than Tibet Weixinkang Medicine Co., Ltd. (15.13%), greater than Harbin Medisan Pharmaceutical Co., Ltd. (-9.30%), less than LanZhou Foci Pharmaceutical Co.,Ltd. (3.27%), less than Beijing Beilu Pharmaceutical Co., Ltd (1.84%), less than Tianjin Tianyao Pharmaceuticals Co., Ltd. (0.53%), less than ZhuZhou QianJin Pharmaceutical Co.,Ltd (10.08%),

Build a custom stock screener for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Starry Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhejiang Starry Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Zhejiang Starry Pharmaceutical Co.,Ltd.'s ROE?

How is the ROE calculated for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)?

What is the highest ROE for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)?

What is the 3-year average ROE for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)?

What is the 5-year average ROE for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)?

How does the current ROE for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) compare to its historical average?